DeFilippis AP et al. |
Fatty acids and TxA(2) generation, in the absence of platelet-COX-1 activity. |
2014 |
Nutr Metab Cardiovasc Dis |
pmid:24370448
|
Gonçalves LH et al. |
Acetylsalicylic acid therapy: influence of metformin use and other variables on urinary 11-dehydrothromboxane B2 levels. |
2014 |
Clin. Chim. Acta |
pmid:24316050
|
|
|
|
|
pmid:24126290
|
Kapłon-Cieślicka A et al. |
Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes. |
2013 |
Kardiol Pol |
pmid:24065375
|
Santilli F et al. |
Effects of high-amount-high-intensity exercise on in vivo platelet activation: modulation by lipid peroxidation and AGE/RAGE axis. |
2013 |
Thromb. Haemost. |
pmid:24030807
|
d'Emmanuele di Villa Bianca R et al. |
Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:24019484
|
DeFilippis AP et al. |
Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction. |
2013 |
Circ. J. |
pmid:23985963
|
Gremmel T et al. |
Differential impact of inflammation on six laboratory assays measuring residual arachidonic acid-inducible platelet reactivity during dual antiplatelet therapy. |
2013 |
J. Atheroscler. Thromb. |
pmid:23739624
|
Hayashi Y et al. |
Immunoaffinity purification of 11-dehydro-thromboxane B2 from human urine and plasma for quantitative analysis by radioimmunoassay. |
1990 |
Anal. Biochem. |
pmid:2372112
|
Nakamura A et al. |
Oral administration of a novel long-acting prostacyclin agonist with thromboxane synthase inhibitory activity for pulmonary arterial hypertension. |
2013 |
Circ. J. |
pmid:23676973
|
Vazzana N et al. |
Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype. |
2013 |
J Am Heart Assoc |
pmid:23557750
|
Davì G et al. |
Thromboxane biosynthesis and platelet function in type II diabetes mellitus. |
1990 |
N. Engl. J. Med. |
pmid:2345567
|
Dharmasaroja PA et al. |
Aspirin nonresponders in patients with ischaemic stroke. |
2013 |
Blood Coagul. Fibrinolysis |
pmid:23429255
|
Carroll RC et al. |
A comparison of VerifyNowR with PlateletMappingR--detected aspirin resistance and correlation with urinary thromboxane. |
2013 |
Anesth. Analg. |
pmid:23302970
|
Dudley A et al. |
Cyclooxygenase expression and platelet function in healthy dogs receiving low-dose aspirin. |
2013 Jan-Feb |
J. Vet. Intern. Med. |
pmid:23278865
|
Olson MT et al. |
Effect of assay specificity on the association of urine 11-dehydro thromboxane B2 determination with cardiovascular risk. |
2012 |
J. Thromb. Haemost. |
pmid:23072449
|
Gautier-Veyret E et al. |
Intermittent hypoxia-activated cyclooxygenase pathway: role in atherosclerosis. |
2013 |
Eur. Respir. J. |
pmid:23060635
|
Yi X et al. |
Platelet response to aspirin in Chinese stroke patients is independent of genetic polymorphisms of COX-1 C50T and COX-2 G765C. |
2013 |
J. Atheroscler. Thromb. |
pmid:22972377
|
Sadilkova L et al. |
The effect of selected pre-analytical phase variables on plasma thromboxane Aâ‚‚ measurements in humans. |
2013 |
Int J Lab Hematol |
pmid:22908995
|
Dragani A et al. |
Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism. |
2012 |
Thromb. Haemost. |
pmid:22782530
|